[go: up one dir, main page]

AU2013902268A0 - Immunotherapy composition (ii) and use thereof - Google Patents

Immunotherapy composition (ii) and use thereof

Info

Publication number
AU2013902268A0
AU2013902268A0 AU2013902268A AU2013902268A AU2013902268A0 AU 2013902268 A0 AU2013902268 A0 AU 2013902268A0 AU 2013902268 A AU2013902268 A AU 2013902268A AU 2013902268 A AU2013902268 A AU 2013902268A AU 2013902268 A0 AU2013902268 A0 AU 2013902268A0
Authority
AU
Australia
Prior art keywords
immunotherapy composition
immunotherapy
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013902268A
Inventor
Mohammed Benghezal
Alma Fulurija
Barry Marshall
Senta WALTON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ondek Pty Ltd
Original Assignee
Ondek Pty Ltd
Filing date
Publication date
Application filed by Ondek Pty Ltd filed Critical Ondek Pty Ltd
Publication of AU2013902268A0 publication Critical patent/AU2013902268A0/en
Priority to JP2016520199A priority Critical patent/JP6495256B2/en
Priority to SG11201510150VA priority patent/SG11201510150VA/en
Priority to EP14813398.6A priority patent/EP3010517A4/en
Priority to CN201480046561.3A priority patent/CN105636601A/en
Priority to BR112015032033A priority patent/BR112015032033A2/en
Priority to AU2014284047A priority patent/AU2014284047B2/en
Priority to CN202411247263.2A priority patent/CN119236063A/en
Priority to US14/897,575 priority patent/US9555104B2/en
Priority to CA2915673A priority patent/CA2915673C/en
Priority to PCT/AU2014/050087 priority patent/WO2014201525A1/en
Priority to US15/381,485 priority patent/US10130704B2/en
Priority to JP2018232441A priority patent/JP2019059770A/en
Abandoned legal-status Critical Current

Links

AU2013902268A 2013-06-21 2013-06-21 Immunotherapy composition (ii) and use thereof Abandoned AU2013902268A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
PCT/AU2014/050087 WO2014201525A1 (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
BR112015032033A BR112015032033A2 (en) 2013-06-21 2014-06-20 IMMUNOTHERAPY COMPOSITION AND USE THEREOF
SG11201510150VA SG11201510150VA (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
EP14813398.6A EP3010517A4 (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
CN201480046561.3A CN105636601A (en) 2013-06-21 2014-06-20 Immunotherapeutic compositions and uses thereof
JP2016520199A JP6495256B2 (en) 2013-06-21 2014-06-20 Immunotherapeutic composition and use thereof
AU2014284047A AU2014284047B2 (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
CN202411247263.2A CN119236063A (en) 2013-06-21 2014-06-20 Immunotherapeutic compositions and uses thereof
US14/897,575 US9555104B2 (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
CA2915673A CA2915673C (en) 2013-06-21 2014-06-20 Immunotherapy composition and use thereof
US15/381,485 US10130704B2 (en) 2013-06-21 2016-12-16 Immunotherapy composition and use thereof
JP2018232441A JP2019059770A (en) 2013-06-21 2018-12-12 Immunotherapeutic composition and use thereof

Publications (1)

Publication Number Publication Date
AU2013902268A0 true AU2013902268A0 (en) 2013-07-04

Family

ID=

Similar Documents

Publication Publication Date Title
IL289821A (en) Compositions and methods for immunotherapy
EP2992097A4 (en) Compositions and methods
EP2951283A4 (en) Compositions and methods
AU2014310479B2 (en) Novel adsorbent composition and use thereof
EP3060561A4 (en) Strigolactone formulations and uses thereof
EP3003390A4 (en) Anti-c10orf54 antibodies and uses thereof
EP3030566A4 (en) Aza-pyridone compounds and uses thereof
EP3042940A4 (en) Low-toxicity sophorolipid-containing composition and use therefor
EP2968503A4 (en) Anti-hepcidin antibodies and uses thereof
EP3065771A4 (en) Methods and compositions for sustained immunotherapy
EP3039131A4 (en) Enzyme composition and uses thereof
EP3010990A4 (en) Adhesive compositions and use thereof
EP2992334A4 (en) Novel phosphatidylalkanols and compositions thereof
EP2983681A4 (en) Therapeutic compositions and uses thereof
EP3010517A4 (en) Immunotherapy composition and use thereof
EP3013361A4 (en) Compositions and methods for immunotherapy
EP3087099A4 (en) Immunotherapy with binding agents
EP3013364A4 (en) Tuberculosis compositions and methods of using the same
EP3041891A4 (en) Materials and methods
EP3059304A4 (en) Novel microorganism and use thereof
EP3048108A4 (en) Thienopiperidine derivative and use thereof
EP3027182A4 (en) Novel copper-cysteamine and methods of use
EP3088413A4 (en) Polypeptide and use thereof as delivery carrier
EP2991949A4 (en) Polysilocarb materials and methods
EP3040329A4 (en) Novel aromatic compound and use thereof